Gerald N. Levy

1.1k total citations
32 papers, 921 citations indexed

About

Gerald N. Levy is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Gerald N. Levy has authored 32 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Pharmacology. Recurrent topics in Gerald N. Levy's work include Carcinogens and Genotoxicity Assessment (7 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and DNA Repair Mechanisms (4 papers). Gerald N. Levy is often cited by papers focused on Carcinogens and Genotoxicity Assessment (7 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and DNA Repair Mechanisms (4 papers). Gerald N. Levy collaborates with scholars based in United States and Taiwan. Gerald N. Levy's co-authors include Wendell W. Weber, Jing‐Gung Chung, David Aminoff, Lourdes Estrada, K J Martell, John S. Anderson, Michael J. Brabec, Ying Liu, Hassan R. Dhaini and Edward J. Kuchinskas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Gerald N. Levy

32 papers receiving 877 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald N. Levy United States 18 509 249 245 155 114 32 921
Michael A. Pereira United States 21 633 1.2× 302 1.2× 153 0.6× 144 0.9× 224 2.0× 42 1.2k
Vernon E. Steele United States 17 502 1.0× 104 0.4× 148 0.6× 125 0.8× 140 1.2× 20 981
Yasushi Kurata Japan 23 465 0.9× 388 1.6× 81 0.3× 95 0.6× 99 0.9× 59 1.2k
K. V. N. Rao United States 21 609 1.2× 370 1.5× 98 0.4× 246 1.6× 235 2.1× 33 1.4k
Isao Eto United States 21 701 1.4× 147 0.6× 112 0.5× 218 1.4× 233 2.0× 51 1.3k
R W Pero Sweden 19 972 1.9× 293 1.2× 133 0.5× 179 1.2× 201 1.8× 42 1.7k
M. Margaret Juliana United States 17 440 0.9× 152 0.6× 105 0.4× 146 0.9× 173 1.5× 31 868
Michael C. Byrns United States 16 386 0.8× 201 0.8× 98 0.4× 131 0.8× 52 0.5× 16 1.2k
Iain G. C. Robertson New Zealand 21 568 1.1× 272 1.1× 83 0.3× 48 0.3× 153 1.3× 49 1.1k
G Bartolini Italy 16 418 0.8× 78 0.3× 151 0.6× 67 0.4× 88 0.8× 45 892

Countries citing papers authored by Gerald N. Levy

Since Specialization
Citations

This map shows the geographic impact of Gerald N. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald N. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald N. Levy more than expected).

Fields of papers citing papers by Gerald N. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald N. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald N. Levy. The network helps show where Gerald N. Levy may publish in the future.

Co-authorship network of co-authors of Gerald N. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald N. Levy. A scholar is included among the top collaborators of Gerald N. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald N. Levy. Gerald N. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhaini, Hassan R. & Gerald N. Levy. (2000). Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population. Pharmacogenetics. 10(1). 79–83. 21 indexed citations
2.
Liu, Ying & Gerald N. Levy. (1998). Activation of heterocyclic amines by combinations of prostaglandin H synthase-1 and -2 with N-acetyltransferase 1 and 2. Cancer Letters. 133(1). 115–123. 18 indexed citations
3.
Chung, Jing‐Gung, et al.. (1997). Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer. Cancer Letters. 111(1-2). 39–50. 17 indexed citations
4.
Liu, Ying, Gerald N. Levy, & Wendell W. Weber. (1997). Induction of human prostaglandin endoperoxide H synthase-2 (PHS-2) mRNA by TCDD. Prostaglandins. 53(1). 1–10. 13 indexed citations
5.
Chung, Jing‐Gung, Hsiu‐Maan Kuo, Tsann Lin, et al.. (1996). Evidence for arylamine N-acetyltransferase in the nematode Anisakis simplex. Cancer Letters. 106(1). 1–8. 25 indexed citations
6.
Ho, Chin Chin, et al.. (1996). Kinetics of acetyl coenzyme A:arylamine N-acetyltransferase from rapid and slow acetylator frog tissues.. Drug Metabolism and Disposition. 24(2). 137–141. 21 indexed citations
7.
Levy, Gerald N., et al.. (1996). Effects of Heredity on Response to Drugs and Environmental Chemicals:  Construction of Rodent Models. Chemical Research in Toxicology. 9(8). 1215–1224. 4 indexed citations
8.
Liu, Ying, Gerald N. Levy, & Wendell W. Weber. (1995). Activation of 2-Aminofluorene by Prostaglandin Endoperoxide H Synthase 2. Biochemical and Biophysical Research Communications. 215(1). 346–354. 10 indexed citations
9.
Levy, Gerald N., et al.. (1994). 2-Aminofluorene metabolism and DNA adduct formation by mononuclear leukocytes from rapid and slow acetylator mouse strains. Carcinogenesis. 15(2). 353–357. 26 indexed citations
10.
Levy, Gerald N., K J Martell, & Wendell W. Weber. (1993). Polymorphic N-acetylation of 2-aminofluorene by cell-free colon extracts from inbred mice. Pharmacogenetics. 3(2). 71–76. 3 indexed citations
11.
Levy, Gerald N.. (1993). DNA-Carcinogen Adducts in Circulating Leukocytes as Indicators of Arylamine Carcinogen Exposure. Fundamental and Applied Toxicology. 21(1). 23–30. 7 indexed citations
12.
Flammang, Thomas J., Letha H. Couch, Gerald N. Levy, Wendell W. Weber, & Carolyn Wise. (1992). DNA adduct levels in congenic rapid and slow acetylator mouse strains following chronic administration of 4-aminobiphenyl. Carcinogenesis. 13(10). 1887–1992. 18 indexed citations
13.
Levy, Gerald N. & Wendell W. Weber. (1992). 2-Aminofluorene-DNA adducts in mouse urinary bladder: effect of age, sex and acetylator phenotype. Carcinogenesis. 13(2). 159–164. 26 indexed citations
14.
Levy, Gerald N., et al.. (1992). Metabolic, molecular genetic and toxicological aspects of the acetylation polymorphism in inbred mice. Pharmacogenetics. 2(5). 197–206. 16 indexed citations
15.
Levy, Gerald N. & Wendell W. Weber. (1990). 2-Aminofluorene-hepatic DNA adducts in congenic mouse lines differing in Ah responsiveness. Carcinogenesis. 11(7). 1233–1235. 6 indexed citations
16.
Levy, Gerald N. & Wendell W. Weber. (1989). 2-Aminofluorene-DNA adduct formation in acetylator congenic mouse lines. Carcinogenesis. 10(4). 705–709. 32 indexed citations
17.
Levy, Gerald N. & Wendell W. Weber. (1988). High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts. Analytical Biochemistry. 174(2). 381–392. 22 indexed citations
18.
Levy, Gerald N. & Michael J. Brabec. (1984). Binding of carbon tetrachloride metabolites to rat hepatic mitochondrial DNA. Toxicology Letters. 22(2). 229–234. 25 indexed citations
19.
Levy, Gerald N., et al.. (1977). Initial reactions in biosynthesis of teichuronic acid of Micrococcus lysodeikticus cell walls.. Journal of Biological Chemistry. 252(10). 3460–3465. 40 indexed citations
20.
Levy, Gerald N., et al.. (1977). Reactions of second stage of biosynthesis of teichuronic acid of Micrococcus lysodeikticus cell walls.. Journal of Biological Chemistry. 252(10). 3466–3472. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026